Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Glycemic Control

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial moderate-sized effects on glycemic control. One study (evidence score 2) showed a significant reduction in HbA1c with a multi-strain probiotic in T2DM patients, but no specific dose or form for L. acidophilus L-92 alone is identified.

  • Studied populations: patients with T2DM

Caveats: Evidence is from reviews that include multiple strains; the specific effect of L. acidophilus L-92 alone is not isolated. Only 1 of 3 studies reported a significant finding, and all studies are reviews with limited methodology.

Generated May 11, 2026
3 of 3 papers
Back to top